Plain-English translation of NCT06643741 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This research study is testing a blood test called the Labcorp Preeclampsia Screen to see how well it can identify pregnant women who may develop preeclampsia — a serious pregnancy condition involving high blood pressure. Researchers will collect blood samples from you at different stages of pregnancy and compare the test results to your actual birth outcomes to understand how accurate the screening test is.
Preeclampsia is a dangerous condition that can threaten both you and your baby's health, but it's hard to predict early in pregnancy. This study aims to develop a better way to identify women at risk so they can receive closer monitoring and earlier treatment.
You likely qualify if…
You likely don't qualify if…
You would have three study visits timed with your regular prenatal care — once in each trimester of pregnancy. At each visit, you'll give a small blood sample and allow researchers to access information from your routine ultrasounds and blood pressure checks. After your baby is born, researchers will review your delivery records and your baby's health outcomes to compare against your earlier screening test results. The test results themselves won't be shared with you or your doctor during pregnancy — the data is only used for research purposes.
AI-generated summary from trial data · Aug 2, 2026 · Not medical advice
United States